In research literature it is commonly referenced as Body Protection Compound 157, and it is frequently used in experimental work where investigators examine peptide signaling in injury and recovery models
Search the registry by batch number to verify integrity
These peptides are studied in controlled environments for their potential roles in skin-related biological pathways, cellular signaling, and tissue-related processes
No Phase 1 or Phase 2 trial has been conducted for PDA as a distinct compound
August Aug 30: Outlook Therapeutics lost nearly three-quarters of its market share after the FDA declined to approve ONS-5010, an investigational ophthalmic formulation of the cancer drug bevacizumab being developed for wet age-related macular degeneration (AMD)
[1] Oral pyridoxine supplements are widely available over the counter, but the injectable form is reserved for situations where high doses are needed rapidly, or the oral route is not feasible